ArticleAmerican journal of translational research2022

Efficacy and mechanism of osimertinib combined with bevacizumab in the treatment of postoperative EGFR positive stage II-IIIA lung adenocarcinoma.

Jian Bao et al.PubMed ↗Full text ↗

No numbers read from the abstract.